SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001213900-19-021026
Filing Date
2019-10-24
Accepted
2019-10-24 18:48:24
Documents
2
Period of Report
2019-10-24

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 5722
2 POWER OF ATTORNEY f3101919ex24_tffpharma.htm EX-24 6345
  Complete submission text file 0001213900-19-021026.txt   13378
Mailing Address 2600 VIA FORTUNA, SUITE 360 AUSTIN TX 78746
Business Address 2600 VIA FORTUNA, SUITE 360 AUSTIN TX 78746 737-802-1973
TFF Pharmaceuticals, Inc. (Issuer) CIK: 0001733413 (see all company filings)

IRS No.: 824344737 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1751 RIVER RUN SUITE 400 FT WORTH TX 76107
Business Address
Fletcher Aaron G.L. (Reporting) CIK: 0001789490 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39102 | Film No.: 191166763